NEWS
Oslo Science CityNew feasibility study
The innovation district Oslo Science City releases a new feasibility study.
DIGI-B-CUBE consortium meets in Oslo
DIGI-B-CUBE aims to unlock the cross-sectoral collaborative potential of small and medium-sized companies.
Meet our new NOME coordinator
Hege Eiklid is the new coordinator of the Nordic Mentor Network for Entrepreneurship (NOME) in Norway.
Oslo Cancer Cluster is a Mature Cluster
Oslo Cancer Cluster is happy to receive the status as a Mature Cluster in the Norwegian Innovation Clusters programme.
Kaiku HealthCollaborating on patient self-monitoring
Patients report their own symptoms in a new project at Ahus, in which the university hospital collaborates with Roche and Kaiku Health.
Ultimovacs to launch new clinical study
Ultimovacs announces a new clinical study in lung cancer.
Eli Lilly & Company in the IMPRESS study
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Lite satsing på kreftinnovasjon
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Brett Jordan/ UnsplashOur role as Changemaker
Did you know that Oslo Cancer Cluster is a changemaker?
